In 2018, Impax Laboratories and Amneal Pharmaceuticals came under one corporate parent and now operate as Amneal Pharmaceuticals. This pharmaceutical company is a publicly listed company traded on the New York Stock Exchange.

Impax Laboratories, LLC is an integrated specialty pharmaceutical company supported by U.S. generics business and a growing branded business. The company is working to build one of the most dynamic pharmaceutical companies in this rapidly changing industry.

The healthcare environment of today demands a new approach and new ideas. The trusted pharmaceutical company Impax Laboratories, LLC stays true to its reputation for quality, service, and value. It is reinventing its processes, playbook and creative partnerships. It mainly focused on delivering outcomes that meet important medical needs, make quality medicines more accessible and more affordable and provide solutions for tomorrow’s health challenges.

The leadership in the company and global colleagues are deeply experienced and forward-thinking. The company holds the capabilities, scale, and resources for growth and success.

The broad portfolio of this Impax Laboratories, LLC l is the foundation from which it makes healthy possible. In the US, its generics portfolio of more than 300 medicines provides people with more affordable access to quality medicines.